Skip to main content
OpenTrials
Completed

NCT Number: NCT00355069

Better Pediatric Asthma Outcomes Through Chronic Care

This 3-year, multi-site study focuses on the translation of cost-effective methods to bring a chronic care model to the care of poor, minority, inner-city children with asthma, at risk of the worst outcomes for the leading chronic disease of children.

The specific aims are to:

1. Develop a computer support system to deliver peer-driven, patient-linked Guideline prompts at the point of care using affordable information technology; 2. Evaluate the effect of the Guideline prompt system on the process and outcomes (symptom control, health-related-quality-of-life, ED and hospitalizations) of asthma care; and 3. Evaluate the added effect on outcomes of family-focused, supportive education delivered by a community health worker.

The key product of the computer support system is a guideline prompt that serves as the mechanism for integrating patient specific data with standards of care. 548 children, ages 5-18, with physician diagnosed asthma, enrolled in one Medicaid Managed Care Organization in CT, and receiving care at one of four Federally Qualified Community Health Centers will be recruited. All sites will have access to the computer support system and the to-be-developed, Guideline-Driven Clinical Standards of Asthma Care. In Phase I (12 months), the effect of prompts delivered at the point of care on patient outcomes will be compared to the effect of no-prompt care. In Phase II (6 months), the effect of family-focused, supportive education will be assessed in combination with prompted care compared to no-prompt care and compared to no education. All patients will receive standard screening and outreach to keep appointments. Data will be obtained from medical records, medical and pharmacy claims data as well as patient and parent interviews at baseline and quarterly for 18 months.

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Connecticut Health Center

Farmington, Connecticut, 06030, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • determined by provider to be asthmatic
  • member of Medical Managed Care Organization partner group

Exclusion criteria

-

Treatment and study plan

electronic (computer based) provider feedback tool

Behavioral

All sites received a Basic Pediatric Chronic Care Model; 2x2 factorial design allocated the additional Medication Assessment Prompt and family education across the four sites as well.

Other names: UCAN Control Asthma Program, Medication Assessment Prompt (MAP)

Primary outcomes

  1. asthma control

    Time frame: assessed at all 5 study visits

  2. guideline appropriate medicating by providers

    Time frame: assessed at all 5 study visits

  3. patient knowledge

    Time frame: assessed at all 5 study visits

Secondary outcomes

  1. self efficacy

    Time frame: assessed at all 5 study visits

  2. social support

    Time frame: assessed at all 5 study visits

Sponsors and collaborators

Lead sponsor

UConn Health

Other

Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

Registry information

Important dates

Study start
2001
Primary completion
2003
Study completion
2003
First posted
Jul 21, 2006
Registry last updated
May 28, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.